Refine Results
  1. "Paul Russo"
Formats
  1. Journal Article (417)
  2. Meeting Abstract (89)
  3. Book Section (10)
  4. Editorial (4)
  5. Conference Paper (2)
  6. Miscellaneous (1)
  7. Research Letter (1)
  8. Review (1)
Groups
  1. Surgery (525)
  2. Genitourinary Disease Management Team (249)
  3. Solid Tumor Oncology Division (109)
  4. Genitourinary Oncology Service (107)
  5. Survivorship Research (98)
  6. Epidemiology and Biostatistics (95)

More Groups

People
  1. Paul Russo (525)
  2. Victor Reuter (103)
  3. Abraham Hakimi (97)
  4. Robert Motzer (90)
  5. Jonathan Coleman (79)
  6. Satish Tickoo (61)

More People

Years
  1. 2021 (6)
  2. 2020 (25)
  3. 2019 (26)
  4. 2018 (20)
  5. 2017 (19)
  6. 2016 (33)

More Years

Publications
  1. Journal of Urology (95)
  2. Urology (51)
  3. Journal of Clinical Oncology (48)
  4. BJU International (40)
  5. European Urology (22)
  6. Urologic Oncology: Seminars and Original Investigations (19)

More Publications

Publishers
  1. Elsevier Science, Inc. (175)
  2. Wiley Blackwell (67)
  3. American Society of Clinical Oncology (49)
  4. Nature Publishing Group (47)
  5. Springer (41)
  6. Elsevier Inc. (33)

More Publishers

Results (525)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: Implications in diagnosis and management
    Journal Article

    Weng, S.; DiNatale, R. G.; Silagy, A.; Mano, R.; Attalla, K.; Kashani, M.; Weiss, K.; Benfante, N. E.; Winer, A. G.; Coleman, J. A.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: An emerging entity with variable clinical course
    Journal Article

    DiNatale, R. G.; Gorelick, A. N.; Makarov, V.; Blum, K. A.; Silagy, A. W.; Freeman, B.; Chowell, D.; Marcon, J.; Mano, R.; Sanchez, A.; more...
    European Urology Focus (2021)

    Fulltext@MSK | Save
  • A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy
    Journal Article

    Alvim, R.; Tin, A.; Nogueira, L.; Lebdai, S.; Wong, N.; Takeda, T.; Assel, M.; Hakimi, A. A.; Touijer, K.; Russo, P.; more...
    International Brazilian Journal of Urology (2021)

    Fulltext@MSK | Save
  • The spinal distribution of metastatic renal cell carcinoma: Support for locoregional rather than arterial hematogenous mode of early bony dissemination
    Journal Article

    Attalla, K.; Duzgol, C.; McLaughlin, L.; Flynn, J.; Ostrovnaya, I.; Russo, P.; Bilsky, M. H.; Hakimi, A. A.; Moss, N. S.
    Urologic Oncology: Seminars and Original Investigations (2021)

    Fulltext@MSK | Save
  • Adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma: Final overall survival analysis of the phase 3 PROTECT trial
    Journal Article

    Motzer, R. J.; Russo, P.; Haas, N.; Doehn, C.; Donskov, F.; Gross-Goupil, M.; Varlamov, S.; Kopyltsov, E.; Lee, J. L.; Lim, H. Y.; more...
    European Urology (2021)

    Fulltext@MSK | Save
  • Editorial comment
    Editorial

    Russo, P.
    Urology (2021)

    Fulltext@MSK | Save
  • A phase III, randomized, placebo-controlled trial of nivolumab or nivolumab plus ipilimumab in patients with localized renal cell carcinoma at high-risk of relapse after radical or partial nephrectomy (CheckMate 914)
    Meeting Abstract

    Bex, A.; Russo, P.; Tomita, Y.; Grunwald, V.; Ramirez, L. M.; McHenry, B. M.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Sarcomatoid renal cell carcinoma: Biology, natural history and management
    Review

    Blum, K. A.; Gupta, S.; Tickoo, S. K.; Chan, T. A.; Russo, P.; Motzer, R. J.; Karam, J. A.; Hakimi, A. A.
    Nature Reviews Urology (2020)

    Fulltext@MSK | Save
  • Historical perspective on partial nephrectomy and renal functional preservation
    Editorial

    Russo, P.
    Urology (2020)

    Fulltext@MSK | Save
  • Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT)
    Meeting Abstract

    Hakimi, A. A.; Voss, M. H.; Kuo, F.; Silagy, A. W.; Marker, M.; Reising, A.; Millholland, J.; Chan, T. A. T.; Russo, P.; Motzer, R. J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save